Percheron Therapeutics's total assets for Q2 2026 were AU$7.90M, a decrease of -36.46% from the previous quarter. PERCF total liabilities were AU$763.70K for the fiscal quarter, a -68.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.